![]() | |
Names | |
---|---|
Preferred IUPAC name
[3-(4-Chlorophenyl)[1,3]thiazolo[3,2-a] [1,3]benzimidazol-2-yl]acetic acid | |
Identifiers | |
CAS Number
|
|
3D model (JSmol)
|
|
ChEMBL |
|
ChemSpider |
|
KEGG |
|
PubChem CID
|
|
UNII |
|
CompTox Dashboard (EPA)
|
|
InChI
| |
SMILES
| |
Properties | |
Chemical formula
|
C17H11ClN2O2S |
Molar mass | 342.80 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references
|
Tilomisole (WY-18,251) is an experimental drug which acts as an immunomodulator and has been studied for the treatment of some forms of cancer.[1][2]
It can also be seen to contain the arylacetic acid moiety that is endemic to many NSAIDs, e.g. ibufenac.[citation needed]